$0.4300
-0.27-38.57%
Ult. Agg.: Oct 8, 7:11 PM
$0.4300
-0.27-38.57%
Sunshine Biopharma (SBFM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.20 | $-1.60 | $-2.70 | $-1.20 |
| Actual | $-1.15 | $-2.50 | $-4.60 | $-1.90 |
| Surprise | +4.17% | -56.3% | -70.4% | -58.3% |
| Revenue | ||||
| Estimate | $8.6M | $9.2M | $10.0M | $12.0M |
| Actual | $9.3M | $8.1M | $8.6M | $9.4M |
| Surprise | +7.72% | -12.1% | -14.2% | -21.5% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.17 | $-0.29 |
| Revenue | ||
| Consensus | $9.6M | $9.8M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-1.15 | $-1.20 | 4.17 % |
| Q1 | May 13, 2026 | $-2.50 | $-1.60 | -56.3 % |
| Q4 | Apr 3, 2026 | $-4.60 | $-2.70 | -70.4 % |
| Q3 | Nov 13, 2025 | $-1.90 | $-1.20 | -58.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $9.26M | $8.60M | 7.72 % |
| Q1 | May 13, 2026 | $8.09M | $9.20M | -12.1 % |
| Q4 | Apr 3, 2026 | $8.58M | $10.00M | -14.2 % |
| Q3 | Nov 13, 2025 | $9.42M | $12.00M | -21.5 % |